drugset / Trial / NCT00159523

Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic

NCT00159523

RandomizedParallel-groupDouble-blindPrevention

Summary

A probiotic (Lactobacillus rhamnosus GG) supplement to pregnant women the last four weeks of pregnancy and three months after birth is expected to give a 40% reduction in risk of atopic sensitisation and allergic disease at two years of age, compared to placebo.

Timeline

Start
2003-12
Primary completion
2007-09
Completion
2007-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium animalis subsp. lactis BB-12 Other / unclassified Oral
Subject Lactobacillus rhamnosus GG Other / unclassified Oral
Subject VSL#3 Other / unclassified Oral